Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.
Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol. 2014 Jul 01; 71(7):896-900.